T. Rowe Price Associates
ALKT icon

T. Rowe Price Associates’s Alkami Technology ALKT Stock Holding History

T. Rowe Price Associates’s Portfolio ALKT Stock Details ALKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
91,879
+18,787
+26% +$310K ﹤0.01% 2097
2026
Q1 		$1.15M Buy
73,092
+13,527
+23% +$249K ﹤0.01% 2089
2025
Q4 		$1.38M Sell
59,565
-1,660
-3% -$36.6K ﹤0.01% 1942
2025
Q3 		$1.52M Buy
61,225
+4,514
+8% +$115K ﹤0.01% 1861
2025
Q2 		$1.71M Buy
56,711
+8,395
+17% +$233K ﹤0.01% 1706
2025
Q1 		$1.27M Buy
48,316
+10,752
+29% +$339K ﹤0.01% 1829
2024
Q4 		$1.38M Buy
37,564
+22,706
+153% +$848K ﹤0.01% 1821
2024
Q3 		$469K Buy
14,858
+851
+6% +$26.9K ﹤0.01% 2274
2024
Q2 		$399K Buy
14,007
+2,505
+22% +$64.7K ﹤0.01% 2285
2024
Q1 		$283K Buy
11,502
+1,460
+15% +$35.8K ﹤0.01% 2460
2023
Q4 		$244K Buy
+10,042
New +$209K ﹤0.01% 2461

Other funds holding ALKT

GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.61B AUM 11.5% 1-Year Est. Return
JPM
JANA Partners Management New York $1.9B AUM 18.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

T. Rowe Price Associates's ALKT Position: Q2 2026 in Review

T. Rowe Price Associates increased its Alkami Technology (ALKT) stake by 26% in Q2 2026, buying an estimated $310K and bringing the position to 91,879 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2097.

T. Rowe Price Associates first reported a position in ALKT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.71M in Q2 2025. 204 funds tracked by Wall St. Rank hold ALKT as of Q2 2026.

  • T. Rowe Price Associates held 91,879 shares of Alkami Technology worth $1.67M as of Q2 2026.
  • T. Rowe Price Associates bought 18,787 Alkami Technology shares in Q2 2026, an estimated $310K.
  • Alkami Technology made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2097 holding.
  • T. Rowe Price Associates first reported a position in Alkami Technology in Q4 2023 and has held it in 11 quarters since.
  • T. Rowe Price Associates's Alkami Technology position peaked at $1.71M in Q2 2025.
  • 204 funds tracked by Wall St. Rank held Alkami Technology as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.